3d Military Medical University develop „superbug vaccine“, active against S. aureus

The team aroud ZOU Quanming is now entering clinical trials with patients 18 – 59 years old to bring this recombinant vaccine to the market, in view of reducing the risks of MRSA infections of compromised patients.

China Bio news release, August 6, 2015

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny